 NAPLES, Fla. , Sept. 9, 2021 PRNewswire -- Enveric Biosciences NASDAQ: ENVB Enveric or the Company, a patient-first biotechnology company developing novel cannabinoid medicines to improve quality of life for cancer patients, today announced that Dr. Joseph Tucker, MagicMed Industries MagicMed Chief Executive Officer, is scheduled to present at the H.C. 